HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 2 filers reported holding HORIZON PHARMA PLC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2018 | $5,000 | -80.0% | 233 | -82.1% | 0.00% | -100.0% |
| Q3 2018 | $25,000 | – | 1,301 | +7127.8% | 0.00% | – |
| Q2 2018 | $0 | -100.0% | 18 | -82.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | -96.6% | 100 | -94.9% | 0.00% | -100.0% |
| Q1 2017 | $29,000 | -9.4% | 1,945 | -2.2% | 0.00% | -50.0% |
| Q4 2016 | $32,000 | -11.1% | 1,989 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $36,000 | -56.6% | 1,995 | -60.3% | 0.00% | -60.0% |
| Q2 2016 | $83,000 | +62.7% | 5,028 | +111.6% | 0.01% | +66.7% |
| Q4 2015 | $51,000 | – | 2,376 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 5,959,819 | $96,430,000 | 10.71% |
| Consonance Capital Management LP | 5,793,903 | $93,745,000 | 10.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 8,956,988 | $144,924,000 | 5.96% |
| JW Asset Management, LLC | 507,075 | $8,205,000 | 5.46% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 6,682,618 | $108,125,000 | 5.23% |
| NEXTHERA CAPITAL LP | 500,000 | $8,090,000 | 4.74% |
| Lion Point Capital, LP | 1,164,414 | $18,840,000 | 4.58% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 4,503,900 | $72,873,000 | 3.52% |
| ARMISTICE CAPITAL, LLC | 650,000 | $10,517,000 | 2.49% |
| SCOPIA CAPITAL MANAGEMENT LP | 8,081,650 | $130,761,000 | 2.48% |